Responses
Clinical/translational cancer immunotherapy
Original research
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
